Dr. Fuster is Assistant Professor, Head of the Hematovascular Pathophysiology Laboratory, and Coordinator of the Atherosclerosis Research Program at CNIC.
The Hematovascular Pathophysiology Laboratory is focused on evaluating new mechanisms that link clonal hematopoiesis to cardiovascular and metabolic disorders, with an especial interest in context of aging. Their research combines human studies, both cross-sectional and longitudinal, to elucidate the associations between CH and cardiovascular disease, and experimental studies to provide causal evidence and mechanisms of action for the observations made in the human cohorts.
Dr. López-Bigas is a Research Professor at the IRBB, Associate Professor at the University Pompeu Fabra, and leader of the Biomedical Genomics lab at IRBB.
The Biomedical Genomics (BBGLab) research group is focused on the study of cancer and somatic tissues in general from a genomics perspective. They have made major contributions in the identification of cancer genes and cancer driver mutations across tumor types; in understanding the mutational processes that lead to the accumulation of mutations in tumors and in the analysis of the effect of chemotherapy in the DNA of treated patients. They have recently started contributed to the study of genes and mutations driving Clonal Hematopoiesis by repurposing tools, concepts originally developed within cancer genomics.
Dr. Bayés-Genís is the Head of ICREC (Heart Failure and Cardiac Regeneration Laboratory) and Director of iCor (Heart Research Institute at IGTP), Cardiology Chief at Trias i Pujol Hospital and Associate Professor at the University Autónoma de Barcelona.
ICREC group focuses on both basic and clinical research approaches to heart failure and cardiac regeneration. They work on the identification of prognostic factors and biomarkers of heart failure progression.
Additionally, they have a translational focus, working also with stem cells and tissue engineering to develop biocompatible patches and polymers to regenerate heart tissue.
Health-in-Code is a company that focuses on people and their mission is to create a positive social impact through personalized medicine and improved clinical decision making based on genomic data, thus increasing the quality of life of people who suffer from genetic diseases and their families, and also contribute to a more efficient and sustainable health system.
Postdoctoral Researcher
Postdoctoral Researcher
Predoctoral Researcher, Severo Ochoa FPI Fellowship
Predoctoral Researcher, FPI Fellowship
The Genomics Unit, led by Ana Dopazo, is dedicated to providing high-quality genomics technology and support to the scientific community at the CNIC and beyond. Currently, the Unit specializes in next generation sequencing (NGS) technologies for genome analysis using Illumina sequencers.
Genomics Technician
Genomics Technician
Grupo Leader and Unit Director
The CNIC Bioinformatics Unit, led by Fátima Sánchez-Cabo, blends the latest developments in Computational Biology and Statistical modelling with deep molecular phenotyping of large human cohorts and animal models to improve our understanding of cardiovascular diseases and also of aging-related disorders.
Group Leader
Bioinformatician
Atheroclonal is a CNIC Project 2024
